Title: DSHEA%20and%20Bioavailability
1DSHEA and Bioavailability
- Elizabeth A. Yetley, Ph.D.
- Ctr. Food Safety Applied Nutrition
- Food and Drug Administration
2Approach
- Regulatory Applications
- How has concept been applied?
- General characteristics
- Specific questions for dietary supplements
- Science and research needs
3Regulatory Applications
4Regulatory Experience
- Drugs -- separate regulations
- Foods -- case-by-case
- Safety
- Labeling
5Food Safety -- Bioavailability
- Safety
- Food additive authorizations
- GRAS status
- GMPs
- Infant formula quality factors
6Safety Example Food Additive
- Olestra
- Must add fat soluble vitamins
- Label information required
7Safety Example -- GRAS
- GRAS -- Nutrients
- Amounts not in excess of that required to produce
intended effect - Levels not to exceed GMPs
8Safety Example -- Finished Products
- Calcium and iron supplements
- Less effective than expected
- High doses of selenium -- low toxicity
- Contaminants
- Mercury
- Lead in calcium supplements
9Safety Example-- Infant Formula
- Infant formula Quality Factors
- Statutory requirement
- Failure to meet --gt adulteration
- Proposed definition
10Food Labeling -- Bioavailability
- Label information
- Nutrition or Supplement Facts declarations
- Claims
- Enriched products
11Label declarations -- History
- Based on analytical amounts
- Nutrients
- Derived from 1968 RDAs
- 1968 RDAs -- some correction for
bioavailability - FDAs compliance method for some nutrients --
microbiological assay
12Label declarations -- History
- Calorie content
- May use specific Atwater factors
- May use specific food factors
- Correct for insoluble dietary fiber
- Correct for protein indigestibility
13Label Declarations -- History
- Non-nutrients
- No correction for bioavailability
14Claims -- History
- Truthful and not misleading
- Meets regulations
- More claims gt 10 RDI
15Health claims -- History
- Calcium and osteoporosis
- Folic acid and neural tube defects
- Meet USP standards dissolution disintegration
- Calcium assimilable
16Enriched products -- History
- Nutrient -- physiologically available
- Level --gt not result in excessive intake
- Nutrient -- suitable for intended purpose
17Enriched products -- History
- Iron and Calcium
- Safe and suitable, or
- Harmless and assimilable
- Research
- Predictive validity of animal bioassays
- Identification relative bioavailability of
ingredient sources
18General principles -- History
- Affects both safety and effectiveness
- Case-by-case
- Physiological effects, not just absorption
- Linked to intended use
- Amounts not to exceed intended effects
- Not to deceive consumer
19Current Marketed D.S. Products
20Ingredients
- Vitamins and minerals
- Macronutrients
- Botanicals
- Amino Acids
- Substances intended to supplement the diet
21Potential Bioavailability Issues
- Source ingredient
- Extraction and processing procedures
- Interactions -- active constituents
- Effects of inert ingredients/coatings
- Interactions
- with diet
- with drugs
22Next Steps -- Science Research
23Issues to be addressed
- Definition What is it?
- Compliance (analytical) methods?
- Specific regulatory impacts
- Safety requirements?
- Label information?
- GMPs?
24Definition Why Discuss?
- When to consider bioavailability?
- How to monitor compliance?
- Substantiation or documentation?
25Definition
- Absorption?
- Digestion?
- Metabolism?
- Excretion?
- Summary Utilization?
26Definitional Challenges?
- Case by case vs. general?
- Ingredient vs. finished product?
27Definitional Challenges?
- New RDIs based on equivalents
- Example Folic acid
- Applicability to other ingredients?
28Definitional Challenges?
- New Upper Limits based on synthetics
- Example Folic acid
- Applicability to other ingredients?
29Safety and Effectiveness Challenges
- How to deal with exposure levels
- Effectiveness
- Safety
- Safety factors for uncertainty
30Host and Use Challenges
- Label information
- Appropriate use conditions
- Vulnerable populations
- Consumer right to know issues
31Other Challenges
- Effect of processing?
- Effect of storage?
32Science and Research Needs
- Bioavailability High priority research need for
CFSAN - Definition
- Analytical methods
- Meaningfulness of measures
33Key issue
- On food - drug continuum
- Where do dietary supplements fall relative to
bioavailability?